Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Matrigel® enhances 3T3-L1 cell differentiation

Josan C., Kakar S., Raha S.

Animal Study on Face & Skin, published in Adipocyte (2021) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Adipocyte (2021)
Reported sample size
—
Source database
Europe PMC
PMID
34288778
PMCID
PMC8296963
DOI
10.1080/21623945.2021.1951985
Citations
17

Abstract (original English)

Culturing cells on bio-gels are believed to provide a more in vivo -like extracellular matrix. 3T3-L1 cells cultured on Matrigel® significantly alteregd their proliferation and differentiation as compared to growth on tissue culture-coated polystyrene surfaces. Growth on a 250-μm thick layer of Matrigel® facilitated the formation of cellular aggregates of 3T3-L1 cells. Differentiation of 3T3-L1 cells cultured on Matrigel® demonstrated increased levels of mRNA levels for key adipogenic transcription factors ( PPARγ, C/EBPα, SREBP1) , lipogenic markers ( FAS, FABP4, LPL, PLIN1 ) and markers of adipocyte maturity ( LEP ), compared to cells cultured directly on a polystyrene tissue culture surface. The gene expression of extracellular matrix proteins ( FN1, COL1A1, COL4A1, COL6, LAM ) was decreased in 3T3-L1 cells cultured on Matrigel®. Furthermore, growth on Matrigel® increased lipid accumulation in 3T3-L1 cells in the presence and absence of rosiglitazone, a thiazolidinedione routinely used to optimize differentiation in these cells. These changes in adipocyte gene expression and lipid accumulation patterns may be a result of the increased cell-cell and cell-ECM interactions occurring on the Matrigel®, a scenario that is more reflective of an in vivo model. Taken together, our data advance the understanding of the value of culturing 3T3-L1 cells on Matrigel®.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
3T3-L1 CellsAnimalsMiceCollagenProteoglycansLamininDrug CombinationsCell DifferentiationAdipogenesis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research